Life Sciences Archive » October, 2007

Life Sciences - October, 2007

164 articles

• Judge Kicks Celebrex Investor Suit For Late Filing
• Judge Grants Injunction Against Patent Rules
• Alza Fights Bid For Attorney-Client Privileged Docs
• SEC Sues Invitrogen Scientist For Insider Trading
• Ev3 To Pay $15.4M To Settle Two Patent Suits
• Ingersoll-Rand To Pay $6.7M Over Oil-For-Food
• Vitamin Shoppe Suit Tossed Amid Settlement Talks
• Jones Day Adds IP Partner To Munich Office
• D.C. Drug Pricing Law Dies, Again
• Wyeth Gets Wage-And-Hour Suit Dropped
• Patents Shrugged: A Frightening Future Looms
• Judge Dismisses Prempro Suit Against Wyeth
• Lawmaker Needles FDA Over Avandia Vote Details
• PTO Rule Opponents Look Hopefully To GSK Case
• Compromise Reached Over Mirapex Expert Witnesses
• Judge Certifies Forest Labs Shareholder Class
• Abbott Faces Antitrust Suit Over HIV Treatments
• German Court Invalidates Lipitor Patent
• Quigley Blasts Objections In Row Over President's Job
• Dusa, River's Edge Settle Acne Drug Patent Dispute
• AstraZeneca Wants To Boot Seroquel "Free-Riders"
• New Rules 75, 78 Unfairly Penalize Research Entities
• Q&A With Foley Hoag's Don Ware
• Bayer Wins Avelox Infringement Case
• FTC Queries Blood Company Over Old Deals
• Ruling Signals End Of Consumer Fraud Suits Over Ads
• Sigma, Oxford Win Claims Construction Battle
• Sanofi, Novo Spar In Insulin Pen Patent Suit—Again
• Ruling Upheld In Appetite Stimulant Patent Feud
• Biovail, J&J Unit Hit Par With Third Ultram Suit
• Diomed Loses Another Summary Judgment Bid
• Former DHB Execs Indicted For Fraud, Insider Trading
• Quigley Plan Gets Approval For Creditor Vote
• JPML Eyes Gadolinium Contrast Agent Cases
• Plaintiff Alleges Glaxo Hid Avandia Risks
• U.K. Court Lets Yeda Continue Case Over Erbitux
• FDA Wants Another "Black Box" Warning For Avandia
• Pfizer Seeks To Quash Report In Nigerian Drug Suit
• AstraZeneca Told To Turn Over Salacious E-Mails
• Q&A With King & Spalding's Courtland L. Reichman
• U.K. Judge Denies Request For Exemplary Damages
• Glaxo Relents, Grants Mylan Paxil License
• Generics Fight Nifedipine Direct Purchaser Class
• FDA To Hold Hearing On Regulations On Salt In Food
• Jury Says Roche's Mircera Infringed Amgen Patents
• Lipitor Patent Upheld By Spanish Appellate Court
• Non-Pioneering Technologies Beware
• Bid To Dismiss Celexa Wrongful Death Suits Denied
• Medtronic Destroyed Defective Device: Suit
• FDA Pushes Back On So-Called Legacy Drugs
• Glaxo Sues Over Breathe Right Strips Patent
• Astellas Resolves Adenoscan Disputes With Teva
• Med Tech Gets Behind Medtronic In High Court Brief
• Cozmed Stole Spinal Device Technology: Kyphon
• FDA Panel Seeks Wider Crackdown On Child Medicine
• Defendants In Vnus' Patent Suit Lose Invalidity Bid
• FDA Announces Changes To ED Drug Labels
• AstraZeneca Can Peek At Lilly Zyprexa Docs: Judge
• Zyprexa Whistleblower Wants To Switch Courts
• Plaintiffs' Firms From Zyprexa Case Seek More Fees
• FTC Opposes Antitrust Exemption For Pharmacists
• Seroquel Plaintiffs Appeal Dismissal Order
• European Panel Revokes Symbicort Patent
• Alston & Bird
• FDA Panel Mulls Child Medicine Crackdown
• IP Litigation Flourishes, Despite Fewer Appeals
• KSR Leads To Increase In Obviousness Invalidations
• Q&A With Latham Watkins' Margaret Zwisler
• FDA Nets New Counsel Masoudi From DOJ
• Baxter Shareholder Can't Appeal Plaintiff Status: Court
• SEC Investigates Medical Device Makers
• Pfizer Quibbles With Plaintiffs Over Mirapex Experts
• Swiss Defendants Get Accutane Claims Dismissed
• First Suits Hit Medtronic In Wake Of Advisory
• SEC Accuses Fund Of Illegal Short Selling
• Boston Scientific Strikes Back In Stent Trial
• Giving The Go-Ahead To Use "Hybrid" Embryos
• Wyeth To Contest Jury Verdict In Prempro Trial
• NutriSystem Faces Shareholder Class Action
• Former Government Adviser Joins Sonnenschein
• Duane Reade Employees Want Class Certification
• Corporate Fraud Is Not Constructed By Plaintiffs' Bar
• Barr, Par Settle With Valeant Over Epilepsy Drug
• Jury Reconsiders $135M Verdict Against Wyeth
• Fulbright Survives Patent Prosecution Malpractice Suit
• Judge Tosses Class Action Against Bausch & Lomb
• Medtronic Stops Sales Of Defibrillator Part
• Oxycontin Maker Says Patents Are Enforceable
• Judge Tosses Hundreds From Bextra Case
• Eisai Files Agreement With Generic Drugmakers
• Abbott Wants U.S. To Cough Up Docs In AWP Suit
• Lawyers Want Wyeth To Hand Over Documents
• Mixed Ruling In Tyco, Ethicon Patent Suit
• Drug Makers Yank Infant Cold Medicines
• Hoffman-La Roche Told To Pay $7M To Accutane User
• Isolagen Underwriters Ask Judge For Reconsideration
• Acorda Sues Apotex Over Proposed Generic Zanaflex
• Judge Lets Barr Build Up Arsenal For Yasmin Suit
• Teva Sues Apotex, Marks 13th Coreg Suit In N.J.
• Sandoz Accuses Eli Lilly Of Inequitable Conduct
• Court Affirms Noninfringement Of Hypertension Drug
• Cordis Says Aneurysm Device Claims Invalid
• Jury Awards $130M In Wyeth Prempro Trial
• NuvaRing Cases Combined For Remand Purposes
• J&J Wins Dismissals In Ditropan XL Litigation
• Freshfields Defeats Partner In Age Discrimination Suit
• German Competition Regulators Raid Bayer
• Depakote ANDA Didn't Violate Injunction: Court
• GE Hit With Another Suit Over Omniscan
• Aredia Plaintiffs Lose Dental Monitoring Bid
• Three Days Into Trial, Cordis Hacks At Boston's Claims
• Barr Strikes Back At Celgene In Thalomid Spat
• PTO Invalidates Novartis Unit's HIV Diagnostic Patent
• Merck, Patients Fight Over Fosamax Discovery Tab
• Doctor Says J&J/Cordis Stents Infringe Patent
• Boston Scientific Fights Bid To Remove Suit To State
• PTO Publishes KSR Obviousness Exam Guidelines
• FTC Pounds Infomercial Co. Over Weight Loss Claims
• Schwarzenegger Bets Big On Statewide Health Care
• Iowa Takes On Drug Industry In New AWP Suit
• Takeda Wins Bid For Stay In Actos Patent Battle
• Circuit Court Tosses $42.5M Medco Settlement
• J&J Hits Back At Red Cross' Motion To Dismiss
• Eli Lilly Adds Warning Labels To Zyprexa
• J&J Unit Sues Hologic For Patent Infringement
• Mylan Strikes Back At Lilly In Strattera Patent Feud
• GE Didn't Warn Patients Of MRI Drug's Risks: Suits
• Abbott Fights Bid To Depose Ex-Pres In AWP Suit
• Avon Wins Lead Plaintiff Role In GSK Securities Suit
• HPV Patent Claims Are Unsustainable: Digene
• Stryker Opposes Stay Of Patent Case
• BSC Fights Bid To Block Thrombosis Info At Stent Trial
• Farmer Fined For Insider Trading In Bank Merger
• Sanofi Sues Mylan Over Prostate Drug — Again
• Former aaiPharma Execs Settle For $7.6M
• Becton Dickinson, Plaintiffs Pull Out Of Syringe MDL
• UCB, Dr. Reddy's, Others Settle Keppra Litigation
• Florida Jury Hands Vioxx Win To Merck
• Varicose Vein Laser Patent Suit Heads To Trial
• Pfizer Wants Mirapex Claims Kicked To Curb
• After Seagate: The New Legal Standard for Willfulness
• AstraZeneca Gets Cases Tossed In Seroquel MDL
• FDA Reveals Plan To Speed Up Generic Drug Review
• FDA To Consider Behind-The-Counter Drugs
• Risperdal Fends Off Generic Competition
• Lilly Seeks To Stay Whistleblower Suit Over Zyprexa
• Celgene Amends Complaint In Thalomid Spat
• Haviland Leaves Suit With Sour Note For Berman
• Pfizer Execs Must Face Nigerian Clinical Trials Suit
• Judge Unseals Some Data From Guidant MDL
• FDA To Investigate Bone Drugs' Effects On Heart
• Becton Settles Antitrust Suit Over Sharps Containers
• Glaxo Hit With Wrongful Death Suit Over Avandia
• Judge Sides With Dentsply In Antitrust Case
• Spouse Of Triangle VP Settles Insider Trading Suit
• High Court Rebuffs Medtronic Over Substitution
• Drug Makers Fight Class Action Over Lice Treatment
• Boston Scientific, Cordis Face Off Over Damages
• Becton Dickinson Targeted Hospital CEOs: Suit
• Pepper Hamilton Lures Partner For Health Group
• Forcing Divestitures, FTC Gives Nod To Mylan Deal
• Apotex Wins As High Court Denies Pfizer Appeal
• Attorneys Get $2.7M In PPA Case
• Iovate Targets Nutrabolics Over Creatine Patents